Steven B. Ketchum, Chief Scientific Officer at AMARIN CORP PLC\UK (AMRN), sold 115,542 shares at $17.49 ($2.0M) on 2019-01-31, disclosed to the SEC on 2019-02-01.
Seasonal sale ($2.0M) by Chief Scientific Officer — this insider has traded AMRN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.94 | 40,482 | $686K | 34.7% |
| 2 | $17.49 | 9,541 | $167K | 8.5% |
| 3 | $17.49 | 9,541 | $167K | 8.5% |
| 4 | $17.06 | 27,989 | $477K | 24.2% |
| 5 | $17.06 | 27,989 | $477K | 24.2% |
| Total | $17.09 avg | 115,542 |
| $2.0M |
| 100% |
| Filing → |
| AMRN | SELL | 2021-01-29 | $6.8M | — | Filing → |
| AMRN | SELL | 2019-05-02 | $356K | — | Filing → |
| AMRN | SELL | 2019-04-01 | $381K | — | Filing → |